nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—VDR—melanoma	0.708	1	CbGaD
Calcitriol—CYP3A4—Temozolomide—melanoma	0.0457	0.576	CbGbCtD
Calcitriol—CYP3A4—Vemurafenib—melanoma	0.0251	0.316	CbGbCtD
Calcitriol—VDR—leg—melanoma	0.00898	0.205	CbGeAlD
Calcitriol—CYP3A4—Docetaxel—melanoma	0.0086	0.108	CbGbCtD
Calcitriol—VDR—hindlimb—melanoma	0.00802	0.183	CbGeAlD
Calcitriol—VDR—appendage—melanoma	0.00688	0.157	CbGeAlD
Calcitriol—VDR—skin epidermis—melanoma	0.00572	0.131	CbGeAlD
Calcitriol—VDR—hair follicle—melanoma	0.00408	0.0932	CbGeAlD
Calcitriol—VDR—neck—melanoma	0.00274	0.0625	CbGeAlD
Calcitriol—Sensory disturbance—Temozolomide—melanoma	0.00247	0.0417	CcSEcCtD
Calcitriol—VDR—eye—melanoma	0.00204	0.0465	CbGeAlD
Calcitriol—Dihydrotachysterol—VDR—melanoma	0.00181	0.232	CrCbGaD
Calcitriol—VDR—skin of body—melanoma	0.00177	0.0405	CbGeAlD
Calcitriol—Neoplasm malignant—Vemurafenib—melanoma	0.00175	0.0296	CcSEcCtD
Calcitriol—VDR—mammalian vulva—melanoma	0.00162	0.0369	CbGeAlD
Calcitriol—Alfacalcidol—VDR—melanoma	0.00116	0.149	CrCbGaD
Calcitriol—Calcidiol—VDR—melanoma	0.00116	0.149	CrCbGaD
Calcitriol—Calcipotriol—VDR—melanoma	0.00116	0.149	CrCbGaD
Calcitriol—VDR—head—melanoma	0.00116	0.0264	CbGeAlD
Calcitriol—Pain in extremity—Vemurafenib—melanoma	0.00109	0.0184	CcSEcCtD
Calcitriol—Apathy—Temozolomide—melanoma	0.00107	0.0181	CcSEcCtD
Calcitriol—Flat affect—Temozolomide—melanoma	0.00106	0.0179	CcSEcCtD
Calcitriol—Paricalcitol—VDR—melanoma	0.00104	0.133	CrCbGaD
Calcitriol—Weight decreased—Vemurafenib—melanoma	0.000849	0.0144	CcSEcCtD
Calcitriol—Ergocalciferol—VDR—melanoma	0.000829	0.106	CrCbGaD
Calcitriol—VDR—lymph node—melanoma	0.00081	0.0185	CbGeAlD
Calcitriol—Phosphatase alkaline increased—Temozolomide—melanoma	0.000764	0.0129	CcSEcCtD
Calcitriol—Redness—Docetaxel—melanoma	0.000753	0.0127	CcSEcCtD
Calcitriol—Erythema multiforme—Vemurafenib—melanoma	0.00071	0.012	CcSEcCtD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000708	0.00693	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000699	0.00683	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—GDF15—melanoma	0.000692	0.00677	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—AKR1B10—melanoma	0.000691	0.00676	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000682	0.00667	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—melanoma	0.000664	0.00649	CbGpPWpGaD
Calcitriol—Erythema—Vemurafenib—melanoma	0.000654	0.0111	CcSEcCtD
Calcitriol—Dysgeusia—Vemurafenib—melanoma	0.00064	0.0108	CcSEcCtD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000639	0.00625	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000638	0.0108	CcSEcCtD
Calcitriol—Cholecalciferol—VDR—melanoma	0.000628	0.0807	CrCbGaD
Calcitriol—Rhinorrhoea—Docetaxel—melanoma	0.000627	0.0106	CcSEcCtD
Calcitriol—VDR—Ovarian Infertility Genes—ATM—melanoma	0.000621	0.00608	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—CDK4—melanoma	0.000619	0.00605	CbGpPWpGaD
Calcitriol—Thirst—Temozolomide—melanoma	0.000583	0.00986	CcSEcCtD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000574	0.00561	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP73—melanoma	0.000574	0.00561	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—NDRG1—melanoma	0.000574	0.00561	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MCL1—melanoma	0.000574	0.00561	CbGpPWpGaD
Calcitriol—Myalgia—Vemurafenib—melanoma	0.000557	0.00942	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000552	0.00935	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—melanoma	0.00055	0.00538	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000536	0.00524	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Vemurafenib—melanoma	0.000533	0.00903	CcSEcCtD
Calcitriol—Bone pain—Docetaxel—melanoma	0.000531	0.00898	CcSEcCtD
Calcitriol—Skin disorder—Vemurafenib—melanoma	0.000518	0.00877	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000518	0.00507	CbGpPWpGaD
Calcitriol—Dehydration—Temozolomide—melanoma	0.000516	0.00873	CcSEcCtD
Calcitriol—Weight decreased—Bleomycin—melanoma	0.000514	0.0087	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CASP10—melanoma	0.000511	0.005	CbGpPWpGaD
Calcitriol—Phosphatase alkaline increased—Docetaxel—melanoma	0.000508	0.0086	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Temozolomide—melanoma	0.0005	0.00845	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.000492	0.00482	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.000492	0.00482	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—PPARG—melanoma	0.00049	0.00479	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000486	0.00822	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.000483	0.00473	CbGpPWpGaD
Calcitriol—Decreased appetite—Vemurafenib—melanoma	0.000464	0.00785	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—melanoma	0.000463	0.00452	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—APAF1—melanoma	0.000459	0.00448	CbGpPWpGaD
Calcitriol—Haemoglobin—Bleomycin—melanoma	0.000457	0.00774	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—ATM—melanoma	0.000457	0.00447	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000457	0.00446	CbGpPWpGaD
Calcitriol—Constipation—Vemurafenib—melanoma	0.000456	0.00772	CcSEcCtD
Calcitriol—Haemorrhage—Bleomycin—melanoma	0.000455	0.0077	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—melanoma	0.000438	0.00428	CbGpPWpGaD
Calcitriol—Weight decreased—Temozolomide—melanoma	0.000434	0.00734	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000432	0.00423	CbGpPWpGaD
Calcitriol—Urinary tract infection—Carmustine—melanoma	0.00043	0.00728	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—VCAN—melanoma	0.000424	0.00415	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000424	0.00718	CcSEcCtD
Calcitriol—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000423	0.00414	CbGpPWpGaD
Calcitriol—Body temperature increased—Vemurafenib—melanoma	0.000422	0.00714	CcSEcCtD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.000419	0.0041	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—CDKN1B—melanoma	0.000419	0.0041	CbGpPWpGaD
Calcitriol—Urinary tract infection—Temozolomide—melanoma	0.000416	0.00703	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MSH2—melanoma	0.000415	0.00406	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000404	0.00395	CbGpPWpGaD
Calcitriol—Erythema multiforme—Dactinomycin—melanoma	0.000401	0.00679	CcSEcCtD
Calcitriol—Haemoglobin—Carmustine—melanoma	0.000399	0.00675	CcSEcCtD
Calcitriol—Haemorrhage—Carmustine—melanoma	0.000397	0.00672	CcSEcCtD
Calcitriol—Erythema—Bleomycin—melanoma	0.000396	0.0067	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.000393	0.00385	CbGpPWpGaD
Calcitriol—Hypersensitivity—Vemurafenib—melanoma	0.000393	0.00665	CcSEcCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARG—melanoma	0.000387	0.00379	CbGpPWpGaD
Calcitriol—Dermatitis bullous—Docetaxel—melanoma	0.000386	0.00653	CcSEcCtD
Calcitriol—Haemoglobin—Temozolomide—melanoma	0.000386	0.00653	CcSEcCtD
Calcitriol—Haemorrhage—Temozolomide—melanoma	0.000384	0.00649	CcSEcCtD
Calcitriol—Asthenia—Vemurafenib—melanoma	0.000383	0.00648	CcSEcCtD
Calcitriol—GC—Metabolism—ACER3—melanoma	0.000381	0.00372	CbGpPWpGaD
Calcitriol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000379	0.00371	CbGpPWpGaD
Calcitriol—Pruritus—Vemurafenib—melanoma	0.000377	0.00639	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MLH1—melanoma	0.000374	0.00366	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.000373	0.00365	CbGpPWpGaD
Calcitriol—Erythema—Dactinomycin—melanoma	0.000369	0.00625	CcSEcCtD
Calcitriol—Pain in extremity—Docetaxel—melanoma	0.000369	0.00624	CcSEcCtD
Calcitriol—Diarrhoea—Vemurafenib—melanoma	0.000365	0.00618	CcSEcCtD
Calcitriol—Erythema multiforme—Temozolomide—melanoma	0.000363	0.00614	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP17A1—melanoma	0.000362	0.00354	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP17A1—melanoma	0.000357	0.00349	CbGpPWpGaD
Calcitriol—Arrhythmia—Carmustine—melanoma	0.000355	0.006	CcSEcCtD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—melanoma	0.000353	0.00345	CbGpPWpGaD
Calcitriol—GC—Metabolism—UGT2B10—melanoma	0.000348	0.00341	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—melanoma	0.000348	0.0034	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—melanoma	0.000347	0.00339	CbGpPWpGaD
Calcitriol—Erythema—Carmustine—melanoma	0.000346	0.00585	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000344	0.00336	CbGpPWpGaD
Calcitriol—Dehydration—Docetaxel—melanoma	0.000343	0.00581	CcSEcCtD
Calcitriol—Vomiting—Vemurafenib—melanoma	0.000339	0.00574	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—melanoma	0.000337	0.0033	CbGpPWpGaD
Calcitriol—Myalgia—Bleomycin—melanoma	0.000337	0.00571	CcSEcCtD
Calcitriol—Chest pain—Bleomycin—melanoma	0.000337	0.00571	CcSEcCtD
Calcitriol—Abdominal pain upper—Docetaxel—melanoma	0.000337	0.0057	CcSEcCtD
Calcitriol—Rash—Vemurafenib—melanoma	0.000336	0.00569	CcSEcCtD
Calcitriol—Dermatitis—Vemurafenib—melanoma	0.000336	0.00569	CcSEcCtD
Calcitriol—Headache—Vemurafenib—melanoma	0.000334	0.00566	CcSEcCtD
Calcitriol—Erythema—Temozolomide—melanoma	0.000334	0.00565	CcSEcCtD
Calcitriol—Discomfort—Bleomycin—melanoma	0.000333	0.00564	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000332	0.00562	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—MAPK1—melanoma	0.00033	0.00323	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Docetaxel—melanoma	0.00033	0.00558	CcSEcCtD
Calcitriol—Dysgeusia—Temozolomide—melanoma	0.000327	0.00554	CcSEcCtD
Calcitriol—GC—Metabolism—HS3ST5—melanoma	0.000324	0.00317	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Bleomycin—melanoma	0.000323	0.00547	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—HDAC2—melanoma	0.000318	0.00311	CbGpPWpGaD
Calcitriol—Agitation—Carmustine—melanoma	0.000318	0.00538	CcSEcCtD
Calcitriol—Nausea—Vemurafenib—melanoma	0.000317	0.00536	CcSEcCtD
Calcitriol—Myalgia—Dactinomycin—melanoma	0.000314	0.00532	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000311	0.00305	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—melanoma	0.000311	0.00304	CbGpPWpGaD
Calcitriol—Discomfort—Dactinomycin—melanoma	0.000311	0.00526	CcSEcCtD
Calcitriol—Anorexia—Bleomycin—melanoma	0.000308	0.00521	CcSEcCtD
Calcitriol—Agitation—Temozolomide—melanoma	0.000307	0.0052	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP1B1—melanoma	0.000305	0.00298	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—melanoma	0.000302	0.00295	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP1B1—melanoma	0.000301	0.00294	CbGpPWpGaD
Calcitriol—Convulsion—Carmustine—melanoma	0.0003	0.00507	CcSEcCtD
Calcitriol—Hypertension—Carmustine—melanoma	0.000298	0.00505	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000294	0.00498	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.000294	0.00288	CbGpPWpGaD
Calcitriol—Myalgia—Carmustine—melanoma	0.000294	0.00498	CcSEcCtD
Calcitriol—Chest pain—Carmustine—melanoma	0.000294	0.00498	CcSEcCtD
Calcitriol—Anxiety—Carmustine—melanoma	0.000293	0.00496	CcSEcCtD
Calcitriol—Convulsion—Temozolomide—melanoma	0.000289	0.0049	CcSEcCtD
Calcitriol—Weight decreased—Docetaxel—melanoma	0.000288	0.00488	CcSEcCtD
Calcitriol—Hypertension—Temozolomide—melanoma	0.000288	0.00488	CcSEcCtD
Calcitriol—Anorexia—Dactinomycin—melanoma	0.000287	0.00486	CcSEcCtD
Calcitriol—Myalgia—Temozolomide—melanoma	0.000284	0.00481	CcSEcCtD
Calcitriol—Anxiety—Temozolomide—melanoma	0.000283	0.0048	CcSEcCtD
Calcitriol—Discomfort—Temozolomide—melanoma	0.000281	0.00476	CcSEcCtD
Calcitriol—Decreased appetite—Bleomycin—melanoma	0.000281	0.00475	CcSEcCtD
Calcitriol—Dry mouth—Temozolomide—melanoma	0.000278	0.00471	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000277	0.0027	CbGpPWpGaD
Calcitriol—Pain—Bleomycin—melanoma	0.000276	0.00468	CcSEcCtD
Calcitriol—Conjunctivitis—Docetaxel—melanoma	0.000276	0.00468	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000275	0.00465	CcSEcCtD
Calcitriol—Anaphylactic shock—Temozolomide—melanoma	0.000273	0.00461	CcSEcCtD
Calcitriol—Anorexia—Carmustine—melanoma	0.000269	0.00455	CcSEcCtD
Calcitriol—Skin disorder—Temozolomide—melanoma	0.000265	0.00448	CcSEcCtD
Calcitriol—Decreased appetite—Dactinomycin—melanoma	0.000262	0.00443	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000261	0.00255	CbGpPWpGaD
Calcitriol—Anorexia—Temozolomide—melanoma	0.00026	0.0044	CcSEcCtD
Calcitriol—Pain—Dactinomycin—melanoma	0.000258	0.00436	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Carmustine—melanoma	0.000257	0.00435	CcSEcCtD
Calcitriol—Urticaria—Bleomycin—melanoma	0.000257	0.00435	CcSEcCtD
Calcitriol—Haemoglobin—Docetaxel—melanoma	0.000257	0.00434	CcSEcCtD
Calcitriol—Body temperature increased—Bleomycin—melanoma	0.000256	0.00432	CcSEcCtD
Calcitriol—Haemorrhage—Docetaxel—melanoma	0.000255	0.00432	CcSEcCtD
Calcitriol—Insomnia—Carmustine—melanoma	0.000255	0.00432	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—melanoma	0.000254	0.00249	CbGpPWpGaD
Calcitriol—Somnolence—Carmustine—melanoma	0.000251	0.00424	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000248	0.0042	CcSEcCtD
Calcitriol—Insomnia—Temozolomide—melanoma	0.000247	0.00417	CcSEcCtD
Calcitriol—Gastrointestinal pain—Dactinomycin—melanoma	0.000246	0.00417	CcSEcCtD
Calcitriol—VDR—Gene Expression—CLNS1A—melanoma	0.000246	0.0024	CbGpPWpGaD
Calcitriol—GC—Metabolism—PLCB4—melanoma	0.000245	0.0024	CbGpPWpGaD
Calcitriol—Decreased appetite—Carmustine—melanoma	0.000245	0.00415	CcSEcCtD
Calcitriol—Somnolence—Temozolomide—melanoma	0.000242	0.0041	CcSEcCtD
Calcitriol—Erythema multiforme—Docetaxel—melanoma	0.000241	0.00408	CcSEcCtD
Calcitriol—Constipation—Carmustine—melanoma	0.000241	0.00408	CcSEcCtD
Calcitriol—Pain—Carmustine—melanoma	0.000241	0.00408	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—HGF—melanoma	0.000241	0.00236	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000241	0.00235	CbGpPWpGaD
Calcitriol—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000241	0.00235	CbGpPWpGaD
Calcitriol—Abdominal pain—Dactinomycin—melanoma	0.000238	0.00403	CcSEcCtD
Calcitriol—Body temperature increased—Dactinomycin—melanoma	0.000238	0.00403	CcSEcCtD
Calcitriol—Hypersensitivity—Bleomycin—melanoma	0.000238	0.00403	CcSEcCtD
Calcitriol—Decreased appetite—Temozolomide—melanoma	0.000237	0.00401	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—melanoma	0.000234	0.00229	CbGpPWpGaD
Calcitriol—Pain—Temozolomide—melanoma	0.000233	0.00395	CcSEcCtD
Calcitriol—Constipation—Temozolomide—melanoma	0.000233	0.00395	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—E2F1—melanoma	0.000233	0.00228	CbGpPWpGaD
Calcitriol—Asthenia—Bleomycin—melanoma	0.000232	0.00392	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000231	0.00226	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Carmustine—melanoma	0.000231	0.0039	CcSEcCtD
Calcitriol—GC—Metabolism—SLC6A11—melanoma	0.000231	0.00226	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIP4K2A—melanoma	0.000231	0.00226	CbGpPWpGaD
Calcitriol—Pruritus—Bleomycin—melanoma	0.000229	0.00387	CcSEcCtD
Calcitriol—Arrhythmia—Docetaxel—melanoma	0.000228	0.00386	CcSEcCtD
Calcitriol—GC—Metabolism—MTAP—melanoma	0.000224	0.00219	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—SPP1—melanoma	0.000224	0.00219	CbGpPWpGaD
Calcitriol—Body temperature increased—Carmustine—melanoma	0.000223	0.00377	CcSEcCtD
Calcitriol—Abdominal pain—Carmustine—melanoma	0.000223	0.00377	CcSEcCtD
Calcitriol—Gastrointestinal pain—Temozolomide—melanoma	0.000223	0.00377	CcSEcCtD
Calcitriol—Erythema—Docetaxel—melanoma	0.000222	0.00376	CcSEcCtD
Calcitriol—Hypersensitivity—Dactinomycin—melanoma	0.000222	0.00376	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—PCNA—melanoma	0.00022	0.00215	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000219	0.00214	CbGpPWpGaD
Calcitriol—Dysgeusia—Docetaxel—melanoma	0.000218	0.00368	CcSEcCtD
Calcitriol—Urticaria—Temozolomide—melanoma	0.000217	0.00367	CcSEcCtD
Calcitriol—Asthenia—Dactinomycin—melanoma	0.000216	0.00366	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—FAS—melanoma	0.000216	0.00211	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000216	0.00211	CbGpPWpGaD
Calcitriol—Body temperature increased—Temozolomide—melanoma	0.000216	0.00365	CcSEcCtD
Calcitriol—Abdominal pain—Temozolomide—melanoma	0.000216	0.00365	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—SKI—melanoma	0.000215	0.0021	CbGpPWpGaD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000213	0.00208	CbGpPWpGaD
Calcitriol—Hypersensitivity—Carmustine—melanoma	0.000208	0.00352	CcSEcCtD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000208	0.00203	CbGpPWpGaD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000207	0.00203	CbGpPWpGaD
Calcitriol—Diarrhoea—Dactinomycin—melanoma	0.000206	0.00349	CcSEcCtD
Calcitriol—Vomiting—Bleomycin—melanoma	0.000206	0.00348	CcSEcCtD
Calcitriol—Rash—Bleomycin—melanoma	0.000204	0.00345	CcSEcCtD
Calcitriol—Dermatitis—Bleomycin—melanoma	0.000204	0.00345	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—ACER3—melanoma	0.000203	0.00199	CbGpPWpGaD
Calcitriol—Asthenia—Carmustine—melanoma	0.000202	0.00343	CcSEcCtD
Calcitriol—Hypersensitivity—Temozolomide—melanoma	0.000201	0.0034	CcSEcCtD
Calcitriol—GC—Metabolism—PHGDH—melanoma	0.0002	0.00196	CbGpPWpGaD
Calcitriol—GC—Metabolism—LUM—melanoma	0.0002	0.00196	CbGpPWpGaD
Calcitriol—GC—Metabolism—HPSE—melanoma	0.000196	0.00192	CbGpPWpGaD
Calcitriol—Asthenia—Temozolomide—melanoma	0.000196	0.00331	CcSEcCtD
Calcitriol—Diarrhoea—Carmustine—melanoma	0.000193	0.00327	CcSEcCtD
Calcitriol—Pruritus—Temozolomide—melanoma	0.000193	0.00326	CcSEcCtD
Calcitriol—GC—Metabolism—CUBN—melanoma	0.000193	0.00188	CbGpPWpGaD
Calcitriol—Convulsion—Docetaxel—melanoma	0.000192	0.00326	CcSEcCtD
Calcitriol—Nausea—Bleomycin—melanoma	0.000192	0.00325	CcSEcCtD
Calcitriol—Hypertension—Docetaxel—melanoma	0.000192	0.00325	CcSEcCtD
Calcitriol—Vomiting—Dactinomycin—melanoma	0.000192	0.00324	CcSEcCtD
Calcitriol—Rash—Dactinomycin—melanoma	0.00019	0.00322	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—melanoma	0.00019	0.00186	CbGpPWpGaD
Calcitriol—Chest pain—Docetaxel—melanoma	0.000189	0.0032	CcSEcCtD
Calcitriol—Myalgia—Docetaxel—melanoma	0.000189	0.0032	CcSEcCtD
Calcitriol—Diarrhoea—Temozolomide—melanoma	0.000187	0.00316	CcSEcCtD
Calcitriol—GC—Metabolism—SDHD—melanoma	0.000186	0.00182	CbGpPWpGaD
Calcitriol—GC—Metabolism—BSG—melanoma	0.000186	0.00182	CbGpPWpGaD
Calcitriol—GC—Metabolism—CSPG4—melanoma	0.000186	0.00182	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—UGT2B10—melanoma	0.000186	0.00182	CbGpPWpGaD
Calcitriol—Dry mouth—Docetaxel—melanoma	0.000185	0.00313	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000184	0.0018	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000184	0.0018	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Docetaxel—melanoma	0.000181	0.00307	CcSEcCtD
Calcitriol—GC—Metabolism—GPAM—melanoma	0.00018	0.00176	CbGpPWpGaD
Calcitriol—Vomiting—Carmustine—melanoma	0.000179	0.00304	CcSEcCtD
Calcitriol—Nausea—Dactinomycin—melanoma	0.000179	0.00303	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—APC—melanoma	0.000179	0.00175	CbGpPWpGaD
Calcitriol—Rash—Carmustine—melanoma	0.000178	0.00301	CcSEcCtD
Calcitriol—Dermatitis—Carmustine—melanoma	0.000178	0.00301	CcSEcCtD
Calcitriol—Headache—Carmustine—melanoma	0.000177	0.00299	CcSEcCtD
Calcitriol—Skin disorder—Docetaxel—melanoma	0.000176	0.00298	CcSEcCtD
Calcitriol—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000175	0.00171	CbGpPWpGaD
Calcitriol—Vomiting—Temozolomide—melanoma	0.000173	0.00293	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—HS3ST5—melanoma	0.000173	0.00169	CbGpPWpGaD
Calcitriol—Anorexia—Docetaxel—melanoma	0.000173	0.00292	CcSEcCtD
Calcitriol—Rash—Temozolomide—melanoma	0.000172	0.00291	CcSEcCtD
Calcitriol—Dermatitis—Temozolomide—melanoma	0.000172	0.00291	CcSEcCtD
Calcitriol—Headache—Temozolomide—melanoma	0.000171	0.00289	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NPPA—melanoma	0.000168	0.00165	CbGpPWpGaD
Calcitriol—Nausea—Carmustine—melanoma	0.000168	0.00284	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—RB1—melanoma	0.000165	0.00162	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000165	0.0028	CcSEcCtD
Calcitriol—Insomnia—Docetaxel—melanoma	0.000164	0.00278	CcSEcCtD
Calcitriol—Nausea—Temozolomide—melanoma	0.000162	0.00274	CcSEcCtD
Calcitriol—Somnolence—Docetaxel—melanoma	0.000161	0.00273	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MMP2—melanoma	0.000159	0.00155	CbGpPWpGaD
Calcitriol—Decreased appetite—Docetaxel—melanoma	0.000158	0.00267	CcSEcCtD
Calcitriol—Constipation—Docetaxel—melanoma	0.000155	0.00262	CcSEcCtD
Calcitriol—Pain—Docetaxel—melanoma	0.000155	0.00262	CcSEcCtD
Calcitriol—GC—Metabolism—PLA2G6—melanoma	0.000153	0.0015	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000152	0.00149	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Docetaxel—melanoma	0.000148	0.00251	CcSEcCtD
Calcitriol—Abdominal pain—Docetaxel—melanoma	0.000143	0.00243	CcSEcCtD
Calcitriol—Body temperature increased—Docetaxel—melanoma	0.000143	0.00243	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BCL2—melanoma	0.000143	0.0014	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000141	0.00138	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MDM2—melanoma	0.000141	0.00138	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000139	0.00136	CbGpPWpGaD
Calcitriol—GC—Metabolism—VCAN—melanoma	0.000138	0.00134	CbGpPWpGaD
Calcitriol—Hypersensitivity—Docetaxel—melanoma	0.000134	0.00226	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—PLCB4—melanoma	0.000131	0.00128	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00013	0.00127	CbGpPWpGaD
Calcitriol—Asthenia—Docetaxel—melanoma	0.00013	0.0022	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000129	0.00126	CbGpPWpGaD
Calcitriol—Pruritus—Docetaxel—melanoma	0.000128	0.00217	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000126	0.00123	CbGpPWpGaD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000125	0.00122	CbGpPWpGaD
Calcitriol—Diarrhoea—Docetaxel—melanoma	0.000124	0.0021	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—PIP4K2A—melanoma	0.000123	0.0012	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC6A11—melanoma	0.000123	0.0012	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—MTAP—melanoma	0.00012	0.00117	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000119	0.00117	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000119	0.00116	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—CDKN1A—melanoma	0.000119	0.00116	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PTEN—melanoma	0.000118	0.00116	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000117	0.00115	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP17A1—melanoma	0.000116	0.00113	CbGpPWpGaD
Calcitriol—Vomiting—Docetaxel—melanoma	0.000115	0.00195	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000114	0.00112	CbGpPWpGaD
Calcitriol—Rash—Docetaxel—melanoma	0.000114	0.00193	CcSEcCtD
Calcitriol—Dermatitis—Docetaxel—melanoma	0.000114	0.00193	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000114	0.00111	CbGpPWpGaD
Calcitriol—Headache—Docetaxel—melanoma	0.000114	0.00192	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000113	0.0011	CbGpPWpGaD
Calcitriol—GC—Metabolism—GNA11—melanoma	0.00011	0.00107	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000109	0.00107	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000108	0.00105	CbGpPWpGaD
Calcitriol—Nausea—Docetaxel—melanoma	0.000108	0.00182	CcSEcCtD
Calcitriol—GC—Metabolism—FASN—melanoma	0.000107	0.00105	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PHGDH—melanoma	0.000107	0.00104	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—LUM—melanoma	0.000107	0.00104	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000106	0.00103	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC5A5—melanoma	0.000105	0.00103	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—RPS3—melanoma	0.000105	0.00103	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—HPSE—melanoma	0.000105	0.00102	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SKI—melanoma	0.000104	0.00101	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—SNRPE—melanoma	0.000104	0.00101	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CUBN—melanoma	0.000103	0.00101	CbGpPWpGaD
Calcitriol—GC—Metabolism—GNAQ—melanoma	0.000102	0.000996	CbGpPWpGaD
Calcitriol—GC—Metabolism—CD44—melanoma	0.000102	0.000996	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.98e-05	0.000976	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SDHD—melanoma	9.93e-05	0.000971	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—BSG—melanoma	9.93e-05	0.000971	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CSPG4—melanoma	9.93e-05	0.000971	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.89e-05	0.000967	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—CDKN2B—melanoma	9.84e-05	0.000962	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP1B1—melanoma	9.77e-05	0.000955	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—EGFR—melanoma	9.63e-05	0.000941	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GPAM—melanoma	9.62e-05	0.00094	CbGpPWpGaD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	9.19e-05	0.000899	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	9.07e-05	0.000887	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	8.97e-05	0.000877	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	8.85e-05	0.000866	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.62e-05	0.000843	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	8.29e-05	0.000811	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PLA2G6—melanoma	8.18e-05	0.000799	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NPPA—melanoma	8.11e-05	0.000793	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP53—melanoma	8.08e-05	0.00079	CbGpPWpGaD
Calcitriol—GC—Metabolism—ABCB1—melanoma	8.04e-05	0.000787	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.45e-05	0.000729	CbGpPWpGaD
Calcitriol—GC—Metabolism—PRKCA—melanoma	7.4e-05	0.000724	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—VCAN—melanoma	7.34e-05	0.000718	CbGpPWpGaD
Calcitriol—GC—Metabolism—ERCC2—melanoma	7.34e-05	0.000718	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH1—melanoma	7.09e-05	0.000693	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.95e-05	0.00068	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.71e-05	0.000656	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARG—melanoma	6.69e-05	0.000654	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP17A1—melanoma	6.2e-05	0.000606	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.11e-05	0.000598	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.08e-05	0.000595	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—melanoma	6.03e-05	0.00059	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HDAC2—melanoma	5.93e-05	0.00058	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GNA11—melanoma	5.85e-05	0.000572	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CG—melanoma	5.8e-05	0.000567	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—FASN—melanoma	5.73e-05	0.00056	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC5A5—melanoma	5.63e-05	0.000551	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPARG—melanoma	5.6e-05	0.000547	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GNAQ—melanoma	5.44e-05	0.000532	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CD44—melanoma	5.44e-05	0.000532	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.33e-05	0.000521	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.31e-05	0.00052	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.28e-05	0.000516	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP1B1—melanoma	5.22e-05	0.00051	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CD—melanoma	5.1e-05	0.000498	CbGpPWpGaD
Calcitriol—GC—Metabolism—ALB—melanoma	5.03e-05	0.000492	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CDKN2B—melanoma	4.74e-05	0.000463	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.7e-05	0.00046	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.64e-05	0.000453	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.6e-05	0.00045	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CB—melanoma	4.44e-05	0.000434	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS2—melanoma	4.4e-05	0.00043	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ABCB1—melanoma	4.3e-05	0.00042	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PRKCA—melanoma	4.26e-05	0.000417	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ERCC2—melanoma	4.22e-05	0.000413	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.96e-05	0.000387	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PRKCA—melanoma	3.95e-05	0.000387	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ERCC2—melanoma	3.92e-05	0.000383	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.9e-05	0.000382	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—melanoma	3.84e-05	0.000375	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—melanoma	3.81e-05	0.000373	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH1—melanoma	3.41e-05	0.000334	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.25e-05	0.000318	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARG—melanoma	3.22e-05	0.000315	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CG—melanoma	3.1e-05	0.000303	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARG—melanoma	2.99e-05	0.000292	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CD—melanoma	2.72e-05	0.000266	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—melanoma	2.71e-05	0.000265	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ALB—melanoma	2.69e-05	0.000263	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ACER3—melanoma	2.64e-05	0.000258	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—UGT2B10—melanoma	2.41e-05	0.000236	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CB—melanoma	2.37e-05	0.000232	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—melanoma	2.35e-05	0.00023	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HS3ST5—melanoma	2.24e-05	0.000219	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—melanoma	2.21e-05	0.000216	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—melanoma	2.05e-05	0.0002	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MAPK3—melanoma	1.89e-05	0.000185	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—melanoma	1.84e-05	0.00018	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PLCB4—melanoma	1.7e-05	0.000166	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIP4K2A—melanoma	1.6e-05	0.000156	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC6A11—melanoma	1.6e-05	0.000156	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—MTAP—melanoma	1.55e-05	0.000152	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—melanoma	1.45e-05	0.000141	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—LUM—melanoma	1.39e-05	0.000136	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PHGDH—melanoma	1.39e-05	0.000136	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—HPSE—melanoma	1.36e-05	0.000133	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CUBN—melanoma	1.33e-05	0.00013	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SDHD—melanoma	1.29e-05	0.000126	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CSPG4—melanoma	1.29e-05	0.000126	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—BSG—melanoma	1.29e-05	0.000126	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—melanoma	1.27e-05	0.000124	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GPAM—melanoma	1.25e-05	0.000122	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—melanoma	1.18e-05	0.000116	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PLA2G6—melanoma	1.06e-05	0.000104	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—VCAN—melanoma	9.53e-06	9.32e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP17A1—melanoma	8.04e-06	7.86e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GNA11—melanoma	7.59e-06	7.43e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—FASN—melanoma	7.43e-06	7.27e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC5A5—melanoma	7.31e-06	7.15e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GNAQ—melanoma	7.06e-06	6.9e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CD44—melanoma	7.06e-06	6.9e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP1B1—melanoma	6.77e-06	6.62e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ABCB1—melanoma	5.57e-06	5.45e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PRKCA—melanoma	5.13e-06	5.02e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ERCC2—melanoma	5.09e-06	4.97e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CG—melanoma	4.02e-06	3.93e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARG—melanoma	3.88e-06	3.79e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CD—melanoma	3.53e-06	3.45e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ALB—melanoma	3.49e-06	3.41e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CB—melanoma	3.08e-06	3.01e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—melanoma	3.05e-06	2.98e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—melanoma	2.66e-06	2.6e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—melanoma	1.88e-06	1.84e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—melanoma	1.53e-06	1.5e-05	CbGpPWpGaD
